학술논문
Immune priming using DC- and T cell-targeting gene therapy sensitizes both treated and distant B16 tumors to checkpoint inhibition
Document Type
Article
Author
Source
In: Molecular Therapy Oncolytics . (Molecular Therapy Oncolytics, 17 March 2022, 24:429-442)
Subject
Language
English
ISSN
23727705